Donate

News

 

October 2025

Welcome to the October 2025 Lymphoma Australia Newsletter

Inside this edition we cover the following topics:

  • Celebrating our community
  • Your chance to shape the future of Chronic Lymphocytic Leukemia (CLL) Treatment & Support in Australia
  • Aggressive Lymphoma Roadmap Launch
  • Upcoming support groups
  • Recent webinar recordings
  • Upcoming education events
  • New treatment updates
  • Sponsor recognition
  • MyHodgkin MyHealth App download available

CLICK HERE to read the newsletter

Cart
Checkout - $0.00
  • 0
  • 1
Share This

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.